Jeffrey S Bishop

Title: The Innovations of Jeffrey S. Bishop

Introduction

Jeffrey S. Bishop is an accomplished inventor based in Spring, TX (US). He has made significant contributions to the field of biomedical research, particularly in the development of epidermal growth factor receptor (EGFR) antagonists. His work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Jeffrey S. Bishop holds a patent for "Epidermal growth factor receptor antagonists and methods of use." This invention features EGFR antagonists that are polypeptide variants of ligands of EGFR. The polypeptide variants possess EGFR antagonistic properties and can inhibit at least one EGFR-mediated biological activity, such as the inhibition of the receptor's kinase activation activity and subsequently, cell proliferation. These polypeptide variants, along with nucleic acids encoding them, can be used therapeutically in situations where inhibition of EGFR activity is indicated. He has 1 patent to his name.

Career Highlights

Jeffrey S. Bishop is associated with Molecular Logix, Inc., where he continues to innovate and develop new therapeutic solutions. His work at the company reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

Some of his notable coworkers include A Katrina Loomis and Daniel J. Monticello. Their collaboration contributes to the innovative environment at Molecular Logix, Inc.

Conclusion

Jeffrey S. Bishop's contributions to the field of biomedical research through his patent on EGFR antagonists highlight his role as a significant inventor. His work has the potential to lead to important advancements in therapeutic applications.